The melanocortin pathway and control of appetite-progress and therapeutic implications
- PMID: 30812013
- PMCID: PMC6500576
- DOI: 10.1530/JOE-18-0596
The melanocortin pathway and control of appetite-progress and therapeutic implications
Abstract
The initial discovery that ob/ob mice become obese because of a recessive mutation of the leptin gene has been crucial to discover the melanocortin pathway to control appetite. In the melanocortin pathway, the fed state is signaled by abundance of circulating hormones such as leptin and insulin, which bind to receptors expressed at the surface of pro-opiomelanocortin (POMC) neurons to promote processing of POMC to the mature hormone α-melanocyte-stimulating hormone (α-MSH). The α-MSH released by POMC neurons then signals to decrease energy intake by binding to melanocortin-4 receptor (MC4R) expressed by MC4R neurons to the paraventricular nucleus (PVN). Conversely, in the 'starved state' activity of agouti-related neuropeptide (AgRP) and of neuropeptide Y (NPY)-expressing neurons is increased by decreased levels of circulating leptin and insulin and by the orexigenic hormone ghrelin to promote food intake. This initial understanding of the melanocortin pathway has recently been implemented by the description of the complex neuronal circuit that controls the activity of POMC, AgRP/NPY and MC4R neurons and downstream signaling by these neurons. This review summarizes the progress done on the melanocortin pathway and describes how obesity alters this pathway to disrupt energy homeostasis. We also describe progress on how leptin and insulin receptors signal in POMC neurons, how MC4R signals and how altered expression and traffic of MC4R change the acute signaling and desensitization properties of the receptor. We also describe how the discovery of the melanocortin pathway has led to the use of melanocortin agonists to treat obesity derived from genetic disorders.
Keywords: AgRP; MC4R; appetite; hypothalamus; leptin; melanocortin.
Conflict of interest statement
Declaration of interest
Authors have no conflicts of interest to disclose.
Figures





Similar articles
-
Multinodal regulation of the arcuate/paraventricular nucleus circuit by leptin.Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):355-60. doi: 10.1073/pnas.1016785108. Epub 2010 Dec 15. Proc Natl Acad Sci U S A. 2011. PMID: 21169216 Free PMC article.
-
Relationship of α-MSH and AgRP axons to the perikarya of melanocortin-4 receptor neurons.Brain Res. 2019 Aug 15;1717:136-146. doi: 10.1016/j.brainres.2019.04.021. Epub 2019 Apr 19. Brain Res. 2019. PMID: 31009611
-
G-protein-independent coupling of MC4R to Kir7.1 in hypothalamic neurons.Nature. 2015 Apr 2;520(7545):94-8. doi: 10.1038/nature14051. Epub 2015 Jan 19. Nature. 2015. PMID: 25600267 Free PMC article.
-
The MC4 receptor and control of appetite.Br J Pharmacol. 2006 Dec;149(7):815-27. doi: 10.1038/sj.bjp.0706929. Epub 2006 Oct 16. Br J Pharmacol. 2006. PMID: 17043670 Free PMC article. Review.
-
Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity.J Endocrinol. 2002 Mar;172(3):411-21. doi: 10.1677/joe.0.1720411. J Endocrinol. 2002. PMID: 11874690 Review.
Cited by
-
Molecular Analysis and Conformational Dynamics of Human MC4R Disease-Causing Mutations.Molecules. 2022 Jun 23;27(13):4037. doi: 10.3390/molecules27134037. Molecules. 2022. PMID: 35807283 Free PMC article.
-
Involvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A.Dis Model Mech. 2022 Jul 1;15(7):dmm049612. doi: 10.1242/dmm.049612. Epub 2022 Jul 26. Dis Model Mech. 2022. PMID: 35765850 Free PMC article.
-
Diagnostic and therapeutic odyssey of two patients with compound heterozygous leptin receptor deficiency.Mol Cell Pediatr. 2020 Nov 3;7(1):15. doi: 10.1186/s40348-020-00107-3. Mol Cell Pediatr. 2020. PMID: 33140236 Free PMC article.
-
Intestinal NUCB2/nesfatin-1 regulates hepatic glucose production via the MC4R-cAMP-GLP-1 pathway.EMBO J. 2025 Jan;44(1):54-74. doi: 10.1038/s44318-024-00300-4. Epub 2024 Nov 19. EMBO J. 2025. PMID: 39562740 Free PMC article.
-
Melanocortin-4 Receptors and Sympathetic Nervous System Activation in Hypertension.Curr Hypertens Rep. 2019 Apr 26;21(6):46. doi: 10.1007/s11906-019-0951-x. Curr Hypertens Rep. 2019. PMID: 31028563 Free PMC article. Review.
References
-
- Adan RAH, Szklarczyk AW, Oosterom J, Brakkee JH, Nijenhuis WAJ, Schaaper WMM, Meloen RH & Gispen WH 1999. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat. European Journal of Pharmacology 378 249–258. - PubMed
-
- Agosti F, Cordisco Gonzalez S, Martinez Damonte V, Tolosa MJ, Di Siervi N, Schioth HB, Davio C, Perello M & Raingo J 2017. Melanocortin 4 receptor constitutive activity inhibits L-type voltage-gated calcium channels in neurons. Neuroscience 346 102–112. - PubMed
-
- Agosti F, Soto EJL, Cabral A, Castrogiovanni D, Schioth HB, Perello M & Raingo J 2014. Melanocortin 4 receptor activation inhibits presynaptic N-type calcium channels in amygdaloid complex neurons. European Journal of Neuroscience 40 2755–2765. - PubMed
-
- Al-Obeidi F, Castrucci AM, Hadley ME & Hruby VJ 1989a. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. Journal of Medicinal Chemistry 32 2555–2561. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous